about
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Biological evaluation of a novel sorafenib analogue, t-CUPMInvolvement of mesenchymal stem cells in cancer progression and metastases.Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.Generation of enhanced definitive endoderm from human embryonic stem cells under an albumin/insulin-free and chemically defined condition.Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells.Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions.Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling.Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice.Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesisJCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.Tumor necrosis factor-alpha-induced reduction of glomerular filtration rate in rats with fulminant hepatic failure.Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction.A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance.Direct comparison of fatty acid ratios in single cellular lipid droplets as determined by comparative Raman spectroscopy and gas chromatography.Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence.Interfering RNA against PKC-α Inhibits TNF-α-induced IP3R1 Expression and Improves Glomerular Filtration Rate in Rats with Fulminant Hepatic Failure.Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro.Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking waterHedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinomaUBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinomaImpaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitisSuccinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementationTargeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway?Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinomaFuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
P50
Q22676705-BE0427FC-FAB5-4E02-A1EE-F52174ADCA00Q35448698-399A0F05-1C64-45B0-9427-7C6104ED4E21Q38331534-43243286-215D-4860-A840-D598D76D2909Q38707438-67C8918E-2F91-41A4-A978-708F14F278B2Q38710554-FDA9A433-FA57-4832-A08A-559052D520CFQ38802155-A1E7CABC-5B81-4148-83D5-D9C940D63E12Q38899847-10285857-12E9-41B5-97EE-2B890B902B7AQ40059071-4CAA494E-6926-4D57-BB0E-97EDA3ECA1B6Q40283115-0639A7CB-ECDD-4675-B89D-E1B55E538742Q40683482-38A7D1B3-76EA-49BB-9BF6-D26EF4ED327BQ41752189-1CA32946-3956-4188-BFC1-7D9D1D00F9B6Q41951705-722300CC-4B01-4EF9-8D84-88BA969927A4Q42212688-B0E8DCBC-2472-4040-827D-EC44AEC74D67Q42216030-ABF925E0-2F45-4A22-BF67-1640F087C7FFQ44372454-9F711657-14C4-467D-B92C-9216D7DBB660Q45003814-279E513A-80EC-4DB5-AAD6-E8EF2168DDDEQ47548320-0CC70A50-0921-448F-BC94-B9D6BA5BA093Q51759687-73E1DCC8-64E9-48E2-8FC8-D97216E0F19AQ54256508-BFF387C8-D864-4110-818D-8437B50CC3A8Q57245901-D88FAE9F-7514-4598-A02B-B338A508C077Q89934692-4DD88C58-3CE7-4430-8950-39A3133A5AB0Q90398674-98F916A8-FF4C-4193-B458-BB58B7FBEC15Q91283915-B9433DA6-FEED-432F-88B6-77DA91050567Q92428796-BB67888C-F675-4A15-A94E-849AEF00E282Q92879016-9BDF5530-A4B4-4B64-A334-F69B9EFF87DCQ93111056-65832B59-1CD4-4EB2-9860-E7EED2CA254CQ95855635-F0E372B8-4CA6-48DE-A378-B52499DA8B96
P50
description
onderzoeker
@nl
professeur d'université (médecine)
@fr
researcher ORCID: 0000-0001-9933-7364
@en
name
Jian Wu
@ast
Jian Wu
@en
Jian Wu
@es
Jian Wu
@fr
Jian Wu
@nl
Jian Wu
@sl
type
label
Jian Wu
@ast
Jian Wu
@en
Jian Wu
@es
Jian Wu
@fr
Jian Wu
@nl
Jian Wu
@sl
altLabel
Jian Wu at UC Davis
@en
prefLabel
Jian Wu
@ast
Jian Wu
@en
Jian Wu
@es
Jian Wu
@fr
Jian Wu
@nl
Jian Wu
@sl
P31
P3835
P496
0000-0001-9933-7364
P569
2000-01-01T00:00:00Z